Evidence map›Paper›PMID 42799263›Full record

ReviewCureus2026

Endoscopic and Histological Diagnosis of Gastrointestinal Amyloidosis: A Narrative Review.

Kai Tuomas Chang, Hanna Mari Chang, Aina Ilona Chang, Minna Chang

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kai Tuomas ChangDepartment of General Surgery, Royal Sussex County Hospital, London, GBR.
Hanna Mari ChangDepartment of Radiology, St George's University Hospitals NHS Foundation Trust, London, GBR.
Aina Ilona ChangDepartment of Histopathology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, GBR.
Minna ChangDepartment of General Medicine, Epsom and St Helier University Hospitals, London, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloidosis encompasses a diverse group of systemic and localised disorders defined by the extracellular accumulation of misfolded proteins, leading to progressive tissue damage and multiorgan dysfunction. Gastrointestinal (GI) involvement is common, yet diagnosis is frequently delayed because symptoms are non-specific and endoscopic findings are equivocal. Recent advances in endoscopic technique, biopsy site selection and advancements in processing of pathological specimens have substantially improved the diagnosis of this condition. Targeted gastrointestinal biopsy, performed during endoscopy, now represents the most reliable approach for early tissue confirmation of amyloidosis. This review examines the topographic distribution of amyloid deposition within the gastrointestinal tract, correlates endoscopic findings with histopathological subtypes and evaluates biopsy positivity rates across different gastrointestinal segments. We also discuss contemporary innovations in endoscopic imaging and sampling instrumentation, alongside practical recommendations for optimising tissue acquisition and analysis. The objective is to provide both a medically and surgically oriented reference that facilitates earlier diagnosis, informs multidisciplinary decision-making and ultimately, improves prognostic outcomes for this subset of patients.

Indexed as

amyloidosiscongo red stainingendoscopygastrointestinal tractimmunohistochemistrymass spectrometrytissue biopsy

Identifiers

PMID42799263
PMCPMC13614764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.